Related Experiment Video
Updated: Apr 3, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Contraception and Pregnancy Planning in Women With Congenital Heart Disease
Kathryn J Lindley1, Shayna N Conner2, Alison G Cahill3
1Department of Medicine, Cardiovascular Division, Washington University in St. Louis, 660 S. Euclid Ave, Campus Box 8086, St. Louis, MO, 63110, USA. klindley@dom.wustl.edu.
Opinion Statement:
The cardiovascular risk of pregnancy among women with congenital heart disease is heterogeneous, ranging from negligible to prohibitively high. Nonetheless, many of these patients do not report being counseled about the potential risks, and the incidence of unintended pregnancy is high. These women should be counseled on safe and effective contraceptive options. Long-acting reversible contraceptives, including the intrauterine devices and etonogestrel implant, are highly effective and safe for all cardiac patients. These are good options for pregnancy planning for women at elevated risk of cardiovascular complications during pregnancy, who are taking potentially teratogenic medications, or who have contraindications to estrogen-containing methods. Pregnancy management begins with pre-conceptual risk stratification and counseling regarding individual cardiovascular and fetal risks. As significant lapse in care is common at the time of transition to adult congenital cardiology care, these discussions ideally begin in pediatric clinics and continue upon transfer of care to adult congenital cardiology clinics.
Related Concept Videos
Birth Control Methods
Mitral Valve Prolapse III: Nursing Management
Rheumatic Heart Disease III: Medical Management
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Mitral Valve Prolapse II: Assessment and Management

